News Merck, Pfizer and Gilead all interested in Medivation buy-ou... Sanofi has competition in its bid to acquire cancer specialist
News Zepatier to add competition to Europe’s hep C market Will company pursue same aggressive pricing strategy in Europe?
Views & Analysis Many millions still untreated – but hep C boom is already ov... Gilead has led a revolution in curing hepatitis C, but now faces a slowdown.
News German pricing changes to hit blockbuster revenues But pharma will be able to negotiate confidential prices.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
